Clinical variables | Univariate regression analysis | Multivariate regression analysis | ||||
---|---|---|---|---|---|---|
Odds ratio | 95% CI | P | Odds ratio | 95% CI | P | |
Gender | 1.363 | 0.807–2.302 | 0.247 | |||
Age | 0.997 | 0.975–1.019 | 0.797 | |||
MR T-stage | 2.172 | 1.177–4.006 | 0.013 | 1.497 | 0.687–3.261 | 0.310 |
MR N-stage | 3.428 | 2.255–5.211 | < 0.001 | 3.549 | 2.153–5.852 | < 0.001 |
MR M-stage | 0.923 | 0.254–3.356 | 0.903 | |||
EMVI | 14.281 | 4.845–42.098 | < 0.001 | 11.456 | 3.366–38.984 | < 0.001 |
Tumor location | 0.687 | 0.565–0.835 | < 0.001 | 0.661 | 0.516–0.846 | 0.001 |
CRM | 0.727 | 0.436–1.211 | 0.041 | 0.404 | 0.198–0.825 | 0.013 |
Morphologic type | 0.409 | 0.224–0.746 | 0.004 | 0.707 | 0.335–1.493 | 0.363 |
ADC value | 1.049 | 0.157–7.021 | 0.960 | |||
Serum CEA level | 1.514 | 0.903–2.539 | 0.116 | |||
Serum CA125 level | 0.6881 | 0.124–3.830 | 0.670 | |||
Serum CA19-9 level | 2.3375 | 1.279–4.272 | 0.006 | 2.356 | 1.139–4.874 | 0.021 |